The Van Andel Research Institute has launched its innovative bioinformatics software system to aid a leading Chicago pediatric research center in diagnosing and treating pediatric diseases. Hospital leaders say the collaboration between the two institutions will more quickly have an impact on human disease.
According to excerpts from the story:
Van Andel Institute (VAI) has entered into a multi-year licensing agreement with Children's Memorial Research Center (CMRC) of Chicago for use of its XenoBase software and database system.
XenoBase is a unique, advanced bio-informatic system created by scientists at Van Andel Research Institute (VARI) to support all aspects of the life sciences from basic research discovery to clinical application. The platform holds great promise for researchers and clinicians who use the system to explore the molecular and clinical basis of disease.
In recent applications, physicians have used the tool to match the molecular profile of tumors of late-stage cancer patients to the most effective therapy, based on molecular evidence.
Read the complete story here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.